IAFP Posttest & Evaluation

Maternal & Infant RSV Vaccination: Implementation and Best Practices for Primary Care Providers

Online Enduring Activity
Post-test, Evaluation, and Certificate Credit Claim
Please complete the online enduring CME activity post-test, evaluation, and credit claim to receive your certificate for the Maternal & Infant RSV Vaccination: Implementation and Best Practices for Primary Care Providers.

Accreditation:
The Illinois Academy of Family Physicians (IAFP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Webinar Credit Designation:
The AAFP has reviewed Maternal & Infant RSV Vaccination: Implementation and Best Practices for Primary Care Providers and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credit(s). Term of Approval is from 08/11/2025 to 08/11/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 - The Illinois Academy of Family Physicians designates this internet live activity for a maximum of 1 AMA PRA Category 1 credit™.
Post-test and Evaluation
PT1. Which of the following best describes the primary benefit of maternal RSV vaccination during pregnancy?*

Prevents RSV transmission through breast milkTransfers protective antibodies to the infantbefore birthStimulates infant immune memoryReplaces the need for monoclonal antibody administration in all infants
PT2. According to current clinical guidelines, when should Abrysvo be administered to a pregnant individual to optimize infant protection against RSV?*

Any time during pregnancyWithin 72 hours of deliveryBetween 32 and 36 weeks of gestationAt the first postpartum visit
PT3. What is a key difference between maternal RSV vaccination and Nirsevimab (Beyfortus) monoclonal antibody administration?*

Maternal vaccination is only effective after birthNirsevimab provides direct passive immunity to the infantNirsevimab is administered during the third trimesterMaternal vaccination is given to the infant at birth
The speaker communicated effectively and accomplished the outlined learning objectives. 1. Describe the burden of RSV disease in infants and the role of maternal and infant immunization strategies in reducing severe outcomes. 2. Explain the most recent clinical recommendations for maternal RSV vaccination (*Abrysvo*) and monoclonal antibodies (Nirsevimab - Beyfortus) use in infants. 3. Differentiate between maternal immunization and infant monoclonal antibody protection, including their mechanisms of action, timing, and target populations. 4. Implement best practices for vaccine administration and management, including proper storage, handling, documentation, and billing for RSV prevention strategies. 5. Develop effective patient communication strategies to address vaccine hesitancy and improve uptake among pregnant individuals and parents of newborns. 6. Integrate RSV vaccination and monoclonal antibody recommendations into routine clinical workflows for family physicians, obstetricians, and pediatricians to ensure comprehensive infant protection.*

Completely AgreeSomewhat AgreeNeither Agree nor DisagreeSomewhat DisagreeCompletely Disagree
This activity will lead to a change in my practice behavior and enhance my clinical skills.*

Extremely LikelyVery LikelySomewhat LikelySlightly LikelyNot at All LikelyNot applicable
This activity will improve my effectiveness in managing and treating patients.*

Extremely LikelyVery LikelySomewhat LikelySlightly LikelyNot at All LikelyNot applicable
This activity contributed to improvements in my patient management practices.*

Completely AgreeSomewhat AgreeNeither Agree nor DisagreeSomewhat DisagreeCompletely DisagreeNot applicable
How much has your KNOWLEDGE increased since participating in this CME activity?*

Not at all / Stayed the sameSlightlySomewhatVery Much
How much has your SKILL level increased since participating in this CME activity?*

Not at all / Stayed the sameSlightlySomewhatVery much
Following this CME activity, how will you plan to change your practice?*

Implement new information or skills into my practiceSeek additional informationDo nothing, as my practice reflects recommendations based on this activityDo nothing, system barriers prevent me from making changes in my practiceOther
What three actions will you take, or changes will you make because of this activity?
What barrier(s) exist within your practice that might prevent you from successfully making changes?
This CME activity included or reflected diversity (e.g., racial/ethnic, gender, sexual orientation, or gender identity).*

YesNoNot applicableOther
This activity was free from commercial bias or influence. If not, please use the comment box to provide detailed feedback.*

YesNo
If bias was detected, what factor(s) do you believe contributed to it?
The presentation was fairly balanced and free of commercial bias.*

Completely AgreeSomewhat AgreeNeither Agree nor DisagreeSomewhat DisagreeCompletely Disagree
I was properly informed about the speaker’s disclosure(s).*

Completely AgreeSomewhat AgreeNeither Agree nor DisagreeSomewhat DisagreeCompletely Disagree
Comment(s) about this CME activity:
Credit Claim and Contact Information
Please indicate which credit you would like to receive*

1 AMA PRA Category 1 credit™1.00 AAFP Prescribed credit(s)
Name*

First NameLast Name
Credentials
Please select your profession from the list below.*

PhysicianPhysician AssistantNurse PractitionerNursePharmacistOther Allied Health ProfessionalOther
Address*

Street Address

Street Address Line 2

CityState / Province

Postal / Zip Code
Email*
example@example.com
Phone Number

Area CodePhone Number
Should be Empty:

Post-test and Evaluation

Credit Claim and Contact Information